Marlex Pharmaceuticals, Inc. has secured final FDA approval for its desvenlafaxine succinate tablet, marking the company’s second serotonin norepineph...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves Generic Bosentan The FDA has approved Actavis Pharma, Inc.'s generic formulation of bosentan (ANDA207110), a pulmonary arterial hypert...
# FDA Approves Generic Bosentan The FDA has approved Zydus Pharmaceuticals USA Inc.'s generic formulation of bosentan, an endothelin receptor antagon...
AMNEAL PHARMS CO. announced the FDA approval of its ANDA submission [Substance], broadening its product portfolio with a potential new entrant in the ...
Sun Pharmaceutical Industries, Inc. received approval for the ANDA209324 application for BOSENTAN (Generic: BOSENTAN), an oral treatment, on April 26,...
# FDA Approves AbbVie's SKYRIZI for Psoriasis Treatment AbbVie Inc. received FDA approval for SKYRIZI (risankizumab-rzaa), a subcutaneous IL-23 inhib...
SpecGx LLC today received FDA approval for its generic version of the ADHD drug Mixed Salts of a Single Entity Amphetamine Product XR, an event that s...
Dr. Reddy’s Laboratories received FDA approval for its testosterone transdermal generic, a move that positions the company to expand its market share ...
On March 26, 2019, the U.S. FDA granted approval to Novartis Pharmaceuticals for Mayzent (siponimod), offering a new oral treatment option for adult p...
NorthStar RxLLC announced today the FDA approval of Tadafil, a generic version of tadalafil with an ANDA 208934, to support the market with bioequival...
FDA has granted tentative approval to Micro Labs Limited for the generic version of dalfampridine tablets, introducing a cost-effective alternative to...
Eywa Pharma Inc. has obtained FDA approval for its generic hydrocodone bitartrate and acetaminophen oral tablets, a regulatory milestone expected to b...
Genentech, Inc. received FDA approval for Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) in early 2019, a formulation designed to significantl...
Rising Pharma Holdings, Inc. announced the FDA’s February 25, 2019, approval of its oral Abiraterone Acetate drug, positioning the company to compete ...
Somerset Therapeutics received final FDA approval on February 20 to market cisatracurium besylate (ANDA 206791), positioning the company to capitalize...
# FDA Approves ANDA for Hibrow Healthcare Hibrow Healthcare received FDA approval for an abbreviated new drug application (ANDA207863) on February 4,...
PAI Holdings, LLC dba PAI Pharma announced the approval of an abbreviated new drug application (ANDA206914) for OxyCODONE HYDROCHLORIDE oral dosage fo...
**LONDON --** AlvaPharma, a portfolio company of Aesica Pharmaceuticals, announced today the FDA approval of its buccal film formulation of buprenorph...
# FDA Approves Organon's ONTRUZANT (Trastuzumab) Biosimilar The FDA has approved Organon LLC's ONTRUZANT (trastuzumab), a biosimilar to Herceptin, ma...
On January 9, 2019, INGENUS PHARMS LLC received FDA approval for ANDA #210985, a move that positions the company to leverage significant market opport...